Megan E. McNally, MD

Megan McNally, MD, is a board-certified and fellowship-trained surgeon with Saint Luke's Surgical Specialists. She treats gastrointestinal cancers, colorectal carcinoma, gastric cancer, hepatobiliary cancers, appendiceal carcinoma and other peritoneal malignancies with intraperitoneal chemotherapy, sarcomas, and skin cancers including melanoma. She also practices general surgery and emphasizes minimally invasive approaches. She is trained in and utilizes da Vinci robotic-assisted surgery.

Dr. McNally graduated from the six-year combined BLA-MD program at the University of Missouri-Kansas City in 2005. She then completed her general surgery residency through the University of Missouri-Kansas City at Truman Medical Centers and Saint Luke's Hospital in 2010. She is board certified with the American Board of Surgery and is a fellow of the Society of Surgical Oncology.

She is a fellowship trained in surgical oncology. She completed a Master's in Medical Science at The Ohio State University in June 2012. Her primary research interest was in the bioinformatic approach to determining associations between micro RNA and outcomes in cholangiocarcinoma. 

She is a native of Pittsburg, Kan., and sought to return close to home to practice. She joined Saint Luke's Health System in August of 2012 to practice surgical oncology and general surgery. Her primary practice locations are Saint Luke's East Hospital and Saint Luke's Hospital on the plaza.

Dr. McNally serves on the General Surgery Coding and Reimbursement Committee for the American College of Surgeons. From that involvement, she serves as the advisor for the ACS to the AMA CPT Editorial Panel. She also serves as the Vice-Chair for the General Surgery residency through University of Missouri-Kansas City.

1. Carter, R., Woodall, C., McNally, M., VanWay, C., Talboy, G. Mixed ductal-endocrine carcinoma of the pancreas. The American Surgeon. 2008 April; 74(4): 338-40.
2. Kenney, R., Talboy, G., McNally, M., Nelson, B. The Effects of Race and Age on Axillary Lymph Node Involvement in Breast Cancer Patients at a Midwestern Safety Net Hospital. 2008 July; Am J Surg 196(1): 64-69.
3. McNally, ME, Moore, BT, Brown, KM. Single-Incision Laparoscopic Colectomy for Colon Cancer. June 2011; Surgical Endoscopy. 25(11):3559-3565.
4. Natalie B. Jones, Megan E. McNally, Lavina Malhotra, Sherif Abdel-Misih, Mark Bloomston, Carl R. Schmidt. Repeat Hepatectomy is Safe But Marginally Effective. Annals of Surgical Oncology. July 2012. 19(7): 2224-2229.
5. Megan E. McNally, Lavina Malhotra, Mark Bloomston, Carl R. Schmidt. Perioperative Mortality in Patients with Myelodysplastic Syndrome. July 2012. Journal of Surgical Oncology. 106(1):46-50.
6. Megan E. McNally, William Carson. Occult Breast Cancer Presenting as Leptomeningeal Carcinomatosis. World Journal of Oncology, Apr 2012. 3(2).
7. David Arrese, Megan E. McNally, Enrique Feria-Arias, Carl Schmidt, Manisha Shah, Mark Bloomston. Presence of Extra-Hepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Carcinoid. In Press. Annals of Surgical Oncology.
8. M. E. McNally, A. Collins, S. Wojcik, J. Liu, J. Henry, J. Jiang, T. Schmittgen, M. Bloomston. Concomitant Dysregulation of miR-151-3p and miR-126 correlates with improved survival in resected cholangiocarcinoma. HPB 2012.
9. Megan E. McNally, Antonio Martinez, Lavina Malhotra, Mark Bloomston, Carl R. Schmidt. Inflammatory Markers are Associated with outcomes in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). Annals of Surgical Oncology. September 2012. 
 

1. Megan E. McNally, Antonio Martinez, Lavina Malhotra, Mark Bloomston, Carl R. Schmidt. Inflammatory Markers are Associated with outcome in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). Annals of Surgical Oncology. September 2012.
2. Beal EW, Albert S, McNally M, Shiley LA, Hanje J, Michaels AJ, Black SM, Bloomston M, Schmidt CR. An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy. J Surg Oncol. 2014 Dec;110(8):967-9. Epub 2014 Aug 25.
3.  Iyer PH, Grant SB, McNally ME, Mouawad NJ, Spaniolas K. The e-volution of the 21st century surgeon. Bull Am Coll Surg. 2014 Aug;99(8):42-8.
4. McNally ME. The importance of detailed documentation in ICD-10. Bull Am Coll Surg. 2015 Aug: 100(8):63-
5. Shirley LA, McNally M, Chokshi R, Jones N, Tassone P, Guy G, Khabiri H, Schmidt C, Shah M, Bloomston M.Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review. World J Surg Oncol. 2015 May 1;13:167.
6. Bothe A, McNally M, Nagele J. 2017 CPT Coding Changes. Bull Am Coll Surg. 2017 Jan;102(1):16-25.
7. Whitacre E, McNally M, Nagele J. Coding for nipple-sparing and skin-sparing mastectomies. Bull Am Coll Surg. 2017 Mar;102(3):29-30.
8. Toor OM, et al. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers. Mol Cancer Ther. 2018 May;17(5):1123-1132.
9. Smith S, McNally M, Nagel J. 2018 CPT coding changes. Bull Am Coll Surg. 2018 Feb 103(1):17.
10. Smith S, McNally M, Nagel J. 2019 CPT coding changes. Bull Am Coll Surg. 2019 Jan.
11. Lieberman J, McNally M, Nagle J. Modifier 51 or 59? How to correctly report multiple procedures. Bull Am Coll Surg. 2019 April.
12. Lieberman J, Smith S, McNally M, Nagle J. ACS responds to frequently asked questions about CPT coding. Bull Am Coll Surg. 2019 Sept.
13. Smith S, McNally M, Nagle J. 2020 CPT coding changes. Bull Am Coll Surg. 2020 Jan.
14. Smith S, McNally M, Lieberman, J. Nagle J. Frequently Asked Questions about CPT Coding. Bull Am Coll Surg. 2022 Aug.

Book Chapters

1. Surgical Oncology. Coding for the Surgeon. Springer Publishing. 2016

Oral Presentations

1. Megan E. McNally, Antonio Martinez, Lavina Malhotra, Mark Bloomston, Carl R. Schmidt. Association of inflammatory markers with outcome in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). ASCO GI Annual Meeting, Jan 2012.
2. Megan E. McNally, Antonio Martinez, Lavina Malhotra, Mark Bloomston, Carl R. Schmidt. Inflammatory Markers are Associated with outcome in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE). SSO Annual Meeting, March 2012.
3.  Xiaoping Zhou, Jonathan Rock, Megan E McNally, Mark Bloomston, Weiqiang Zhao, Gerard Lozanski and Wendy L Frankel. MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma. Submitted to the United States and Canadian Academy of Pathology (USCAP) 2012 Annual Meeting.
4. M. E. McNally, A. Collins, S. Wojcik, J. Liu, J. Henry,       J. Jiang, T. Schmittgen, M. Bloomston. Concomitant Dysregulation OF mir-151-3P and mir-126 Correlates with Improved Survival in Resected Cholangiocarcinoma. AHPBA Annual Meeting, March 2012.
5. Megan E. McNally, David Arrese, Enrique Feria-Arias, Carl Schmidt, Manisha Shah, Mark Bloomston. Presence of Extra-Hepatic Disease Should Not Preclude Transarterial Chemoembolization for Metastatic Carcinoid. 7thInternational Regional Perfusion Conference, Feb 2012.
6. Megan E. McNally, D. Arrese, E. Feria-Arias, G. Guy, H. Khabiri, C. Schmidt, M. Shah, M. Bloomston. Survival Advantage after Transarterial Chemoembolization for Operable Metastatic Carcinoid Reflects Tumor Biology Rather Than Efficacy. 7th International Regional Perfusion Conference, Feb 2012.
7. Natalie B. Jones, Megan E. McNally, Lavina Malhotra, Sherif Abdel-Misih, Mark Bloomston, Carl R. Schmidt. Repeat Hepatectomy is Safe But Marginally Effective. Society of Surgical Oncology Annual Meeting, San Antonio, Texas. March 2011.
8. McNally, ME, Moore, BT, Brown, KM. Single Incision Laparoscopic Colectomy for Colon Cancer. Missouri Chapter of the American College of Surgeons, Kansas City, Missouri. June 2010.
9. McNally, ME, Moore, BT, Brown, KM. Single Incision Laparoscopic Colectomy for Colon Cancer. Kansas City Surgical Society, Kansas City, Missouri. June 2010.
10. McNally, ME, Moore, BT, Brown, KM. Single Incision Laparoscopic Colectomy for Colon Cancer. St. Luke’s Hospital Resident Research Day, Kansas City, Missouri. May 2010.
11. Megan McNally, Emmanuel Daon, Kimberly M. Brown, B. Todd Moore, Keith Allen Is Minimally Invasive Esophagectomy Appropriate in a Community-Based Hospital? International Society of Minimally Invasive Cardiothoracic Surgery, San Francisco, CA. June 2009.
12. Megan McNally, Benoit Blondeau. Klippel-Trenaunay Syndrome: An Overview; International Lymphedema Society; Nov 2007, Kansas City, Missouri. November 2007.

Invited Presentations

1. ACS GSCRC Committee. ME McNally et al ACS Webinar on New Split/Shared and Critical Care Services. April 2022.
2. ACS GSCRC Committee. ME McNally et al ACS Webinar on Major Changes for 2021 Office E/M Coding. March 2021.
3. Megan E. McNally, invited lecture, Updates in surgical management of melanoma, Surgical Grand Rounds, UMKC, Nov 2019 
4. Megan E. McNally, invited lecture, Updates in surgical management of melanoma, Missouri Chapter ACS, May 2017
5. Megan E. McNally, invited lecture, Updates in ERAS Pathways, Missouri Chapter ACS, May 2017
6. Megan E. McNally, invited lecture, Grand Rounds, University of Missouri-Kansas City, General Surgery Coding, December 2017
7. Megan E. McNally, invited lecturer, Lee’s Summit, Minimally Invasive Surgery Today, October 2014
8. Megan E. McNally, invited lecturer, Saint Luke’s East Hospital, Senior Advisory Committee, Surgical Oncology in Eastern Jackson County. October 2013.
9. Megan E. McNally, invited lecturer, Saint Luke’s East Hospital, Senior Education, Screening and Treatment of Colorectal Cancer. April 2013.
10. Megan E. McNally, invited lecturer, Grand Rounds, University of Missouri-Kansas City, Management of Malignant Bowel Obstruction. September 2012.
11. Megan E. McNally, invited lecturer, Perioperative Management of the GI Surgical Patient. Saint Luke’s East Hospital, August 2012.
12. Megan E. McNally, invited lecturer, Grand Rounds, The Ohio State University, The bioinformation approach to defining the role of miRNA’s association with prognosis in cholangiocarcinoma. March 2012. 
13. McNally, ME. Current Guidelines in Gastroesophageal Junction Cancer. Tumor Board, Truman Medical Center, Kansas City, Missouri. April 2010.

Poster Presentations

1. Megan E. McNally, Sherif Abdel-Misih, Lavina Malhotra, Scott Albert, Carl Schmidt, Mark Bloomston. After Pancreatectomy, Any Rise in CA 19-9 is a Harbinger of Recurrent Pancreatic Cancer and Dismal Survival. SSO Annual Meeting, March 2012.
2.  Megan E. McNally, Natalie B. Jones, Lavina Malhotra, Sherif Abdel-Misih, Edward W. Martin, Mark Bloomston, Carl R. Schmidt. Even in the Best Patients, Recurrence Rates are High after Hepatectomy for Metastatic Colon Cancer. Society of Surgical Oncology, San Antonio, Texas. March 2011.
3. Megan E. McNally, Katie Murray, Naredra Khare. Adrenal Cysts: Management and a Review of the Literature.Missouri Chapter of the American College of Surgeons, Kansas City, Missouri. June 2010.
4. Megan E. McNally, B. T. Moore, Kimberly M. Brown. Single Incision Laparoscopy for Colon Cancer. Society of Surgical Oncology, St. Louis, Missouri. March 2010.